Uncover: K-Beauty Science, African Skin, Kenyan Ownership

Uncover, a Nairobi-based skincare brand founded in 2021, secured $1.4 million in seed funding to expand into the United States, Ghana and Uganda. Its pitch is precise: 'K-Beauty meets African botanicals' — lab-developed, dermatologist-approved formulas built specifically for melanated skin, a segment global beauty has long underserved.

The brand personalises through data: quizzes and app inputs feed product development done in collaboration with South Korean labs. It is African market insight and ownership paired with imported formulation science — a hybrid model rather than a purely local one.

The bet is that melanated skin is a large, underserved and loyal market, and that an African brand with a genuine market read plus credible science can win it before a global incumbent bothers to. Raising to expand into the US as well as Ghana and Uganda signals an ambition beyond the region — to serve the African skin market wherever it lives.

The move is to marry two credibilities: the technical authority of K-beauty science and the cultural authority of building for African skin from Nairobi. Neither alone is novel; together, aimed at a segment the majors treat as an afterthought, it is a defensible position.

Confirmed: Uncover, founded in Nairobi in 2021, raised $1.4 million in seed funding to expand into the US, Ghana and Uganda, corroborated by Empower Africa, AfroTech and earlier CNN coverage.

Confirmed: The brand builds dermatologist-approved, lab-developed formulas for melanated skin, combining K-beauty science with African botanicals and app-based personalisation.

Reported independently: The founding team is reported as Jade Oyateru and Sneha Mehta, with some coverage also naming Catherine Lee — the exact line-up varies by outlet.

Reported independently: The collaboration with South Korean labs and the app-data personalisation method are described in company and interview sources.

Not claimed at this stage: Revenue, customer numbers and unit economics are not disclosed.

Not claimed at this stage: The $1.4m is seed-stage capital; the outcome of the US/Ghana/Uganda expansion is unproven.

The authorship is largely African — a Kenya-based brand, an African co-founder, an African-skin market it understands better than any global incumbent — with an honest asterisk: the formulation science leans on Korean labs. That is not a failing; it is a pragmatic hybrid, and the ownership and the market read stay African. The prize is to convert that read into scale before a global beauty giant notices the segment and outspends it. The risk is the usual seed-stage one: distribution and capital against much deeper pockets.

Serve the segment the majors ignore. Melanated skin is large, loyal and underserved by global beauty. An African brand with a real market read can own it — if it moves before an incumbent decides the category is worth the spend.

Borrowed science, owned market. Leaning on Korean lab science is not a weakness when the market insight, the brand and the ownership are African. The hybrid is the strategy, not a compromise.

The Nairobi founding, the $1.4m seed round, the melanated-skin positioning and the K-beauty-plus-African-botanicals model are confirmed across independent tech and business press. The exact founder line-up and the Korean-lab method are reported and vary slightly by outlet. No revenue or unit economics are disclosed; the expansion outcome is unproven.